N-acetyl-b-D-glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality

URN to cite this document:: urn:nbn:de:bvb:355-epub-445286
DOI to cite this document:: 10.5283/epub.44528

Allgaier, Raphael

; Strack, Christina ; Wallner, Stefan ; Hubauer, Ute ; Uecer, Ekrem ; Lehn, Petra ; Keyser, Andreas ; Luchner, Andreas ; Maier, Lars

; Jungbauer, Carsten

Preview

License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 26 Jan 2021 16:32

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Aims Chronic heart failure may lead to chronic kidney disease. Previous studies suggest tubular markers N-acetyl-b-D-glucosaminidase (NAG) and Kidney-injury-molecule-1 (KIM-1) as potential markers for the cardiorenal syndrome (CRS). The prognostic value of NAG and KIM-1 regarding implantable cardioverter defibrillator (ICD) shock therapies is unknown. Methods We included 314 patients with an ICD ...